Interview with Dr. Giulia Pascolini: Unravelling the Genetic Underpinnings of Dermatological Anomalies
Dr Giulia Pascolini, an esteemed Italian M.D. and Ph.D., is currently responsible for the Genetic Counselling Service of the Istituto…
The article describes that Greenwood Genetic Center has partnered with FDNA to utilize its advanced phenotyping technology, particularly the Face2Gene platform, for analyzing patients with rare diseases. Face2Gene harnesses artificial intelligence and deep learning to evaluate facial features, helping clinicians identify phenotypic markers indicative of genetic disorders. By integrating this cutting-edge technology, the Greenwood Genetic Center aims to enhance the accuracy and speed of rare disease diagnoses. This collaboration highlights the growing importance and effectiveness of AI-driven phenotyping technology in genetics, providing a more precise decision support tool that benefits patients through early identification and tailored treatment strategies.
Dr Giulia Pascolini, an esteemed Italian M.D. and Ph.D., is currently responsible for the Genetic Counselling Service of the Istituto…
Founded in 2017, the Spanish Coffin Siris Syndrome Association is an organization dedicated to supporting families affected by this rare…
Dr. Karen Gripp, Erin Wadman & Carolina Alves talk about the delineation of a new syndrome associated with prenatal fentanyl…